Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$991M |
| 2 |
Broadcom
AVGO
|
+$941M |
| 3 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$859M |
| 4 |
Amazon
AMZN
|
+$858M |
| 5 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
+$756M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$425M |
| 2 |
Merck
MRK
|
+$379M |
| 3 |
ASML
ASML
|
+$336M |
| 4 |
Yum China
YUMC
|
+$311M |
| 5 |
Microchip Technology
MCHP
|
+$306M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.73% |
| 2 | Financials | 12.43% |
| 3 | Industrials | 11.73% |
| 4 | Healthcare | 10.66% |
| 5 | Consumer Discretionary | 10.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3576
ASP Isotopes
ASPI
$446M
| $53.8K | ﹤0.01% |
19,343
+217
| +1% | +$577 |
|
|
AMRN
3577
Amarin Corp
AMRN
$297M
| $53.6K | ﹤0.01% |
4,277
+1,311
| +44% | +$17.4K |
|
3578
Kaltura
KLTR
$209M
| $53.5K | ﹤0.01% |
39,319
+2,802
| +8% | +$3.45K |
|
3579
Paysign
PAYS
$517M
| $53.4K | ﹤0.01% |
14,541
-32,844
| -69% | -$150K |
|
3580
MeiraGTx Holdings
MGTX
$1.08B
| $53K | ﹤0.01% |
12,701
+535
| +4% | +$2.31K |
|
3581
PDS Biotechnology
PDSB
$37.4M
| $52.8K | ﹤0.01% |
13,815
+641
| +5% | +$2.14K |
|
3582
Seres Therapeutics
MCRB
$45M
| $52.2K | ﹤0.01% |
2,761
+798
| +41% | +$16.2K |
|
3583
Lantronix
LTRX
$223M
| $50.7K | ﹤0.01% |
+12,314
| New | +$46.4K |
|
3584
Information Services Group
III
$204M
| $50.4K | ﹤0.01% |
15,275
-85,491
| -85% | -$280K |
|
3585
1stdibs.com
DIBS
$148M
| $50K | ﹤0.01% |
11,335
-347
| -3% | -$1.57K |
|
3586
Denison Mines
DNN
$2.43B
| $48.6K | ﹤0.01% |
26,567
-1,405
| -5% | -$2.47K |
|
|
KYNB
3587
Kyntra Bio
KYNB
$27.4M
| $48.3K | ﹤0.01% |
4,837
+3,460
| +251% | +$52.2K |
|
3588
Karyopharm Therapeutics
KPTI
$155M
| $48.3K | ﹤0.01% |
3,877
+1,176
| +44% | +$14.6K |
|
3589
Veru
VERU
$35.5M
| $48.1K | ﹤0.01% |
6,261
-11
| -0.2% | -$95 |
|
3590
Rigetti Computing
RGTI
$4.39B
| $48K | ﹤0.01% |
61,339
-2,688
| -4% | -$2.45K |
|
3591
Puma Biotechnology
PBYI
$398M
| $47.8K | ﹤0.01% |
18,742
-100,090
| -84% | -$303K |
|
3592
Cardiff Oncology
CRDF
$63M
| $47.5K | ﹤0.01% |
17,805
-375
| -2% | -$886 |
|
|
QIPT
3593
DELISTED
Quipt Home Medical
QIPT
| $47.2K | ﹤0.01% |
16,158
-99,094
| -86% | -$306K |
|
3594
Acumen Pharmaceuticals
ABOS
$152M
| $45.1K | ﹤0.01% |
18,189
-797
| -4% | -$2.16K |
|
|
RGLS
3595
DELISTED
Regulus Therapeutics
RGLS
| $44.4K | ﹤0.01% |
28,253
-808
| -3% | -$1.34K |
|
3596
CytomX Therapeutics
CTMX
$690M
| $44.2K | ﹤0.01% |
37,464
+14,370
| +62% | +$18.3K |
|
|
LUNA
3597
DELISTED
Luna Innovations Incorporated
LUNA
| $43.7K | ﹤0.01% |
18,575
+6,821
| +58% | +$17.5K |
|
3598
Harvard Bioscience
HBIO
$27.6M
| $43.4K | ﹤0.01% |
1,612
-8,293
| -84% | -$244K |
|
|
VXRT
3599
DELISTED
Vaxart
VXRT
| $43.3K | ﹤0.01% |
50,995
+2,824
| +6% | +$2.16K |
|
3600
Atomera
ATOM
$173M
| $43.2K | ﹤0.01% |
+16,434
| New | +$51.2K |
|
Similar funds
Invesco's Q3 2024 Portfolio in Review
As of Q3 2024, Invesco held 3,952 positions worth $518B, up 9.5% from $473B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Invesco's Q3 2024 filing shows 81 new, 1,757 increased, 1,790 reduced and 200 closed positions. Its largest new stake was iShares 3-7 Year Treasury Bond ETF: 6,397,900 shares worth $765M. The largest sale was Advanced Micro Devices, an estimated $425M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Industrials.
- Invesco's largest Q3 2024 buy was iShares 3-7 Year Treasury Bond ETF: 6,397,900 shares worth $765M.
- Invesco added most to Apple in Q3 2024, an estimated $991M increase.
- Invesco's biggest Q3 2024 reduction was Advanced Micro Devices, cutting an estimated $425M.
- Invesco fully exited WestRock Company in Q3 2024, selling an estimated $196M.
- Invesco's ten largest holdings make up 18% of its $518B portfolio in Q3 2024.
- Invesco opened 81 new positions and closed 200 in Q3 2024.
- Invesco's portfolio value rose 9.5% quarter-over-quarter to $518B.
Based on Invesco's 13F filing for Q3 2024, filed 12 Nov 2024.